Evidence map›Paper›PMID 41801342›Full record

ArticleInnere Medizin (Heidelberg, Germany)2026

[Prevention and prophylaxis in angiology].

Oliver J Müller, Norbert Weiss

Abstract readEnglish Abstract
PubMed Publisher
In one paragraph

Article in Innere Medizin (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Oliver J MüllerKlinik für Innere Medizin V, Universitätsklinikum Schleswig-Holstein, Arnold-Heller-Str. 3, 24105, Kiel, Deutschland. oliver.mueller@uksh.de.
Norbert WeissUniversitäts GefäßCentrum & Medizinische Klinik und Poliklinik III, Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, Fetscherstraße 74, 01307, Dresden, Deutschland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vascular diseases develop over decades. Avoidable exposures, such as tobacco use and insufficient implementation of evidence-based prevention strategies contribute to the progression. For angiology, prevention and prophylaxis therefore means an integrated approach to structural prevention, primary prevention and secondary prevention. Structural prevention particularly addresses nicotine products, including e‑cigarettes/vapes and nutrition, such as reducing sugar in processed foods. Primary prevention includes risk-adapted early detection and risk reclassification, which do not rely on population-based screening but on clearly defined target groups with immediate therapeutic consequences. In the case of manifest atherosclerotic disease, secondary prevention aims to prevent subsequent events, such as progression of peripheral arterial occlusive disease (PAOD), myocardial infarction or stroke. Of particular relevance is the consistent implementation of supervised exercise training (SET) for intermittent claudication, as despite clear recommendations there is still a significant deficit in implementation on a broad scale. In Germany, the framework conditions for prevention and healthcare are basically in place (e.g., health check-ups, ultrasound screening for abdominal aortic aneurysm in men above the age of 65 years) but risk-adapted vascular risk stratification, reliable reimbursement and cross-sectoral programs such as SET/vascular exercise are not yet sufficiently systematized. This article identifies best practices, redundancies, evidence gaps and concrete areas for improvement and formulates practice-oriented and health policy-relevant lines of development.

Indexed as

Vascular DiseasesGermanyHumansPrimary PreventionRisk FactorsSecondary PreventionConditional/structural preventionDelivery of health careScreeningSupervised exercise trainingVascular disease

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.